Maria A. Zarzour

Statistics

Publications

Citations

525

H-Index

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Wisconsin Carbone Cancer Center

Maria A. Zarzour is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and clinical trials in sarcoma.

ORCID

Publications per year

2016–2024

Publications

Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial

Neeta Somaiah, Anthony P. Conley, Edwin R. Parra et al. · The Lancet Oncology · 2022 · 157 citations

Medicine, Oncology, Pharmacology +16

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients

Gustavo Schvartsman, Behrang Amini, Chrystia M. Zobniw et al. · Scientific Reports · 2017 · 42 citations · Full text

Medicine, Oncology, Pharmacology +9

Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion

Vivek Subbiah, Oliver Holmes, Kyle Gowen et al. · Oncology · 2016 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

<scp>Real‐world</scp> use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center

Elise F. Nassif, Brandon Cope, Raymond Traweek et al. · International Journal of Cancer · 2022 · 37 citations

Medicine, Oncology, Surgery +13

PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma

Amanda Parkes, Elizabeth Urquiola, Priya Bhosale et al. · Sarcoma · 2020 · 30 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

1–5 of 16